↓ Skip to main content

Amitriptyline versus placebo for major depressive disorder

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
3 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
157 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Amitriptyline versus placebo for major depressive disorder
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd009138.pub2
Pubmed ID
Authors

Claudia Leucht, Maximilian Huhn, Stefan Leucht

Abstract

Amitriptyline is a tricyclic antidepressant that was synthesised in 1960 and introduced as early as 1961 in the USA, but is still regularly used. It has also been frequently used as an active comparator in trials on newer antidepressants and can therefore be called a 'benchmark' antidepressant. However, its efficacy and safety compared to placebo in the treatment of major depression has not been assessed in a systematic review and meta-analysis.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Germany 2 1%
Unknown 153 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 21%
Researcher 26 17%
Student > Bachelor 16 10%
Student > Ph. D. Student 14 9%
Other 10 6%
Other 31 20%
Unknown 27 17%
Readers by discipline Count As %
Medicine and Dentistry 62 39%
Psychology 15 10%
Nursing and Health Professions 11 7%
Agricultural and Biological Sciences 11 7%
Social Sciences 10 6%
Other 15 10%
Unknown 33 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2018.
All research outputs
#2,928,382
of 12,544,629 outputs
Outputs from Cochrane database of systematic reviews
#5,630
of 10,351 outputs
Outputs of similar age
#54,691
of 257,179 outputs
Outputs of similar age from Cochrane database of systematic reviews
#308
of 526 outputs
Altmetric has tracked 12,544,629 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,351 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 257,179 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 526 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.